Graft versus host disease

A rare disease that occurs after allogeneic hematopoietic stem cell transplant and is a reaction of donor immune cells against host tissues. Activated donor T cells damage host epithelial cells after an inflammatory cascade that begins with the preparative regimen.

Anemia

A reduction in erythrocytes volume or hemoglobin concentration.


Total: 3

                       


(per page)
PMID (PMCID)
23291149
 MALE Adult
Kidney complications of hematopoietic stem cell transplantation.
Singh N, McNeely J, Parikh S, Bhinder A, Rovin BH, Shidham G.
Am J Kidney Dis. 2013;61(5):809-21.
Hematopoietic stem cell transplantation (HSCT) exposes a patient's kidneys to a unique combination of challenges, including high-dose radiation, anemia, chemotherapeutic agents, graft-versus-host disease, opportunistic infections, attenuated and altered immunologic responses, fluid and electrolyte imbalances, and extensive courses of antimicrobial agents.
17876419
 FEMALE
Chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation: case report.
Lorenzoni PJ, Scola RH, Carsten AL, Trentin AP, Teive HA, Pasquini R, Werneck LC.
Arq Neuropsiquiatr. 2007;65(3A):700-4.
We describe a 17-year-old woman with a diagnosis of acute myeloid leukemia due to Fanconi's anemia who was submitted to allogeneic HSCT and developed CIDP as part of graft-versus-host disease.
8171385
 MALE Adult
[Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma].
Garcia Gala JM, Ramirez Payer A, Rayon C, Rodriguez Vicente P, Roson C, Blanco C.
Sangre (Barc). 1993;38(6):489-91.
We report a case of a graft-versus-host disease (GVHD) in a patient with non Hodgkin Lymphoma who received multiple blood transfusion for anemia and thrombocytopenia.